S2 E1:The convergence of Consumer Packaged Goods and Biotech. Capital efficiency and unit economics.

Update: 2022-12-05

Description

Elizabeth Edwards is the Founder and Managing Partner of H Venture. Elizabeth focuses on early-stage science-based consumer brands at the convergence of CPG and BioTech. She discusses advice to early-stage founders on how to navigate current market conditions, capital efficiency, unit economics, and supply chain impact on margin. She also provides insight into defining a path to profitable growth through unit economics at scale and revenue milestones.

Our host James Mackey, SecureVision CEO

Listen to our full episode list here:
https://www.scalebydesign.io/

Follow us:
https://www.linkedin.com/company/scalebydesign/

Our YouTube channel:
https://www.youtube.com/@securevision1677

#1 Rated Embedded Recruitment Firm on G2!
https://www.g2.com/products/securevision/reviews

Thanks for listening!

Comments

In Channel

S2 E16: The Future of Technology: Exploring the Top Sectors, Trends, and Financing Market w Mark Sherman

2023-03-2223:54

S2 E15: Expert Panel. The current economic environment. Fundraising & How VC's are working alongside and advising PortCos in 2023 w Doug Landis, Scott Barker & Brandon Metcalf.

2023-02-2239:06

S2 E14: The Journey of Starting A Micro VC Focused on Student Startups w Gaurav Mehta.

2023-02-1527:05

S2 E13: Maximizing Employee Engagement During Economic Downturns: Strategies for Valuing and Retaining Talent w Raluca Mackey

2023-02-0831:51

S2 E11: The current state of the tech industry's labor market. Talent acquisition strategies for 2023 w Asad Zaman

2023-01-2553:03

S2 E10: The impact of capital market uncertainty on early-stage funding. VC and climate tech w Eren Uman

2023-01-1842:35

S2 E9: Investing in BIPOC, the crypto crash and market trends, products with no differentiating value props w Michael Benezra & Noah Ente

2023-01-1047:22

S2 E8: How to make the career transition into VC. The vast range of opportunity in ClimateTech w David J. Neff

2023-01-0335:02

S2 E7: The value propositions of an operator-led fund. Tapping into the power of the LP community w Scott Barker, GTMfund Co-founder

2022-12-2841:07

S2 E6: Next-gen commerce and how to uncover investment opportunities that most investors miss w Michael Nogen

2022-12-2241:18

S2 E5: Why pharma startups need to innovate the drug development process. The importance of a patient first approach w Leen Kawas

2022-12-2047:25

S2 E4: Synthetic biology’s potential to change the world. How the shortfall of semi-commercial fermentation capacity is stunting development of new products w Jason Webber

2022-12-1554:10

S2 E3: A new way to think about co-founding and bringing scientific products to market. How BioTech will change the world w Vikram Chaudhery and Paul Conley

2022-12-1344:33

S2 E1:The convergence of Consumer Packaged Goods and Biotech. Capital efficiency and unit economics.

2022-12-0537:45

EP 16: Capacity planning, conversion rates & when it makes sense to hire externally w Jen Spencer

2022-11-1740:11

EP 15: Being intentional with your ideal customer profile w/ Patrick Hudgins

2022-10-2846:03

EP 14: Dragons vs Unicorns and the Downside of High Valuations w/ Ross Wolfe, Founding Partner & Managing Director of Diab Venture Partners

2022-10-1138:20

EP 13: Ushering in the next evolution of personalized customer engagement w/Lio Slama, CEO at AskNeo

2022-09-3042:31

EP 12: Scaling ERGs that generate business outcomes w/Anisha Nandi, CEO at Verbate.io

2022-09-2337:19

EP 11: Defining the new category of revenue observability w/Neetha Ratakonda

2022-09-2041:44

00:00

S2 E1:The convergence of Consumer Packaged Goods and Biotech. Capital efficiency and unit economics.

#box-pro-ellipsis-176174853342985{-webkit-line-clamp:2;}S2 E1:The convergence of Consumer Packaged Goods and Biotech. Capital efficiency and unit economics.

S2 E1:The convergence of Consumer Packaged Goods and Biotech. Capital efficiency and unit economics.

SecureVision

S2 E1:The convergence of Consumer Packaged Goods and Biotech. Capital efficiency and unit economics.